#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA-activated mutation Acute myeloid leukaemia Cytokine release syndrome Thyroid cancer metastatic Retinopathy of prematurity Epileptic encephalopathy Breast cancer metastatic Monogenic diabetes Cutaneous lupus erythematosus Thrombotic thrombocytopenic purpura Proteus syndrome Erdheim-Chester disease Astrocytoma malignant Lennox-Gastaut syndrome Kaposi's sarcoma More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Basic Information Lysosomal storage disorder – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Sjogren’s syndrome Mitochondrial myopathy – Basic Information Mastocytosis – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Treatment Progressive supranuclear palsy Osteosarcoma metastatic – Diagnostics Arterial tortuosity syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etamsylate JNJ-75276617 Losartan Potassium Bisoprolol Tecovirimat Interferon Beta-1A Epcoritamab Riboflavin Sodium Phosphate Foscarnet ARFOLITIXORIN Iron Sucrose Crofelemer BMS-986470 COBALAMIN Ucart20X22 MAGNESIUM ACETATE TETRAHYDRATE Rifabutin Nvdx3 Gandotinib Metreleptin More therapies…

    Learn about Your Condition

    Nervous system disorder Graft infection Head and neck cancer stage IV Respiratory failure Meningococcal infection Chondropathy Insulin resistance Dermatitis atopic Weaning failure Osteomyelitis acute Pemphigoid Open angle glaucoma Intestinal ischaemia Mucopolysaccharidosis III Neuromyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus

    Recruiting

    2 1
    Investigated Drugs:
    • VENT-03
    Bulgaria Czechia France Hungary Poland Spain

  • Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Carboplatin
    France Greece Italy Poland Romania

  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Gemcitabine
    • Cisplatin
    • Durvalumab
    France

  • Evaluation of 68Ga-FAPI PET/CT scan effectiveness in monitoring treatment response in patients with peritoneal metastases receiving intraperitoneal chemotherapy

    Recruiting

    1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • Evaluating Elacestrant alone or with leuprorelin in premenopausal women with early-stage hormone receptor positive breast cancer before surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Elacestrant Dihydrochloride
    • Leuprorelin Acetate
    France

  • Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia refractory
    • T-cell type acute leukaemia
    • Acute myeloid leukaemia
    Spain
Previous Page
1 … 139 140 141 142 143 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!